Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... radiotherapy, or immunotherapy, or corticosteroids ( prednisone up to 20 mg/day or its equivalent is permitted for chronic ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  2. Drugs

    ... C ellcept prednisone numerous names ...

    Page last updated 03/02/2016 - 9:11am.

  3. 8-Chloro-Adenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    ... except for maintenance dose of steroids ( prednisone 10 mg/day or less) At least 2 weeks from prior ...

    Clinical Trial last updated 05/23/2016 - 3:25pm.

  4. Pure Red Cell Aplasia (PRCA)

    ... on an ongoing basis. Corticosteroids, like prednisone , are often the initial treatment for PRCA. Unfortunately, the ...

    Topic section last updated 07/07/2016 - 3:14pm.

  5. Disease Won't Run My Life

    ... be a rock of strength for me every day. A round of prednisone made my face balloon and added twenty pounds with no improvement ...

    Patient Chronicle last updated 05/10/2016 - 3:36pm.

  6. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... using systemic corticosteroids (daily doses </= 10 mg of prednisone or equivalent) or topical or inhaled corticosteroids. ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  7. PNH Drug Information

    ... N eupogen prednisone numerous names ...

    Page last updated 01/20/2015 - 4:56pm.

  8. MDS Drug Information

    ... C ellcept prednisone Z arnestra, T ...

    Page last updated 01/20/2015 - 4:46pm.

  9. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... drugs are excluded: mycophenolate, cyclosporine , prednisone > 20mg/day, or immunosuppressive agents DONOR: Personal or ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  10. CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

    ... at the time of CD8+ memory T-cell infusion; prednisone at a physiologic dose of 5 mg per day or less is allowed ...

    Clinical Trial last updated 04/29/2016 - 12:36pm.